The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience

Vaccine

Volumn 15, Issue 16, 1997, Pages 1737-1740

  Whittle, Belinda L ^a   Verma, Naresh K ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Epitope; Salmonella; Vaccine

Indexed keywords

EPITOPE; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA DUBLIN; SALMONELLOSIS;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; B-LYMPHOCYTES; BACTERIAL VACCINES; ENCEPHALITIS VIRUS, MURRAY VALLEY; EPITOPES; FEMALE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; SALMONELLA; SALMONELLA VACCINES; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0030866822     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00119-9     Document Type: Article

References (22)

1. Hormaeche, C. E., Khan, C. M. A., Mastroeni, P., Villareal, B., Dougan, G. and Chatfield, S. N. Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In: Molecular and Clinical Aspects of Vaccine Development (Eds Ala Aldeen D. and Hormaeche, C. E.). John Wiley, Chichester, UK, 1995, pp. 119-153
2. Germanier, R. and Furer, E. Isolation and characterisation of ga/E mutant Ty21a of Salmonella typhi: a candidate strain for live, oral typhoid vaccine. Journal of Infectious Diseases 1975, 131, 553-558.
3. McFarland, W. C. and Stocker, B. A. D. Effect of different purine auxotrophic mutations on mouse virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microbial Pathogenesis 1987, 3, 129-141.
4. Curtiss III, R. and Kelly, S. M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infection and Immunity 1987, 55, 3035-3043.
5. Stocker, B. A. D. Auxotrophic Salmonella typhi as live vaccine Vaccine 1988, 6, 141-145.
6. Sad, S., Malini Gupta, H., Talwar, G. P. and Raghupathy, R. Carrier-induced suppression of the antibody response to a 'self' hapten. Immunology 1991, 74, 223-227.
7. Schutze, M-p., Leclerc, C., Jolivet, M., Audibert, F. and Chedid, L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. Journal of Immunology 1985, 135, 2319-2323.
8. Lise, L. D., Mazier, M., Jolivet, M., Audibert, F., Chedid, L. and Schlesinger, D. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier. Infection and Immunity 1987, 55, 2658-2661.
9. John, D. D., Torres, J. R., Murillo, J., Herrington, D. A., Wasserman, S. S., Cortesia, M. J., Losonsky, G. A., Sturcher, D. and Levine, M. M. Effect of priming with carrier on response to conjugate vaccine. Lancet 1989, 2, 1415-1418
10. Schutze, M-P, Leclerc, C., Vogel, F. R. and Chedid, L. Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms. Cellular Immunology 1987, 104, 19-90.
11. Leclerc, C., Schutze, M-P., Deriad, E. and Przewlocki, G. The in vivo elimination of cd4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression. Journal of Immunology 1990, 145, 1343-1349.
12. Schutze, M-P., Deriaud, E., Przewlocki, G. and Leclerc, C. Carrier-induced epitopic suppression is initiated through clonal dominance. Journal of Immunology 1989, 142, 2635-2640.
13. Sad, S., Rao, K., Arora, R., Talwar, G. P. and Raghupathy, R. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope. Immunology 1992, 76, 599-603.
14. Chabalgoity, J. A., Vallareal-Ramos, B., Anjam Khan, C. M., Chatfield, S. N., Hormaeche, R. D. and Hormaeche, C. E. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier. Infection and Immunity 1995, 63, 2564-2569.
15. Bao, J. X. and Clements, J. D. Prior immunological experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. Infection and Immunity 1991, 59, 3841-3845.
16. Newton, S. M. C., Jacob, C. O. and Stocker, B. A. D. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 1989, 244, 70-72.
17. Whittle, B. L., Lee, E., Weir, R. C. and Verma, N. K. Immune response to a murray valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella. Journal of Medical Microbiology 1997, 46, 129-138.
18. Engvall, E. and Perlmann, P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry 1971, 8, 871-875.
19. Deschenes, M., Guenounou, M., Ronco, E., Vacheron, F. and Nauciel, C. Impairment of lymphocyte proliferative responses and interleukin-2 production in susceptible (C57BL/6) mice infected with Salmonella typhimurium. Immunology 1986, 58, 225-230.
20. Killar, L. M. and Eisenstein, T. K. Delayed-type hypersensitivity and immunity to Salmonella typhimurium. Infection and Immunity 1986, 52, 504-508.
21. Lee, J-C., Gibson, C. W. and Eisenstein, T. K. Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium. Cellular Immunology 1985, 91, 75-91.
22. Eisenstein, T. K., Huang, D., Meissler, J. J. and al-Ramadi, B. Macrophage nitric oxide mediates immunosuppression in infectious inflammation. Immunobiology 1994, 191, 493-502.